MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjcard.2018.02.046

Медицинская библиотека · The American journal of cardiology · 2018

Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial).

Dudek Dariusz, Ebner Adrian, Sobczyński Robert, Trębacz Jarosław, Vesga Boris, Granada Juan, Zembala Marian, Witkowski Adam, Van Mieghem Nicolas M, Sood Poornima, Ochała Andrzej, Dziewierz Artur, Żmudka Krzysztof

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

This study aimed to evaluate the use of the HeartMate percutaneous heart pump, a catheter-based axial flow pump designed to provide partial left ventricular support, in patients who underwent high-risk percutaneous coronary intervention (PCI). Patients who are hemodynamically unstable, or at risk of being hemodynamically unstable, while undergoing PCI may require mechanical circulatory support. Fifty high-risk patients were enrolled in a prospective, nonrandomized, multicenter, open-label trial. Primary end points were freedom from hemodynamic compromise during PCI and a composite measure of major adverse events. Patients were followed for 30 days. No patient met the primary performance end point. Six safety end points in 5 patients occurred, including 1 access site complication requiring intervention, 1 cerebrovascular accident, 2 major bleeding complications, and 2 cases of new or worsening aortic insufficiency. No cardiac deaths, myocardial infarctions, or surgical interventions occurred. In conclusion, initial results of the HeartMate percutaneous heart pump for mechanical circulatory support during high-risk PCI are encouraging. Hemodynamic stability was achieved in all patients with a low incidence of adverse events.

Для цитирования: Dudek Dariusz, Ebner Adrian, Sobczyński Robert, Trębacz Jarosław, Vesga Boris, Granada Juan, Zembala Marian, Witkowski Adam, Van Mieghem Nicolas M, Sood Poornima, Ochała Andrzej, Dziewierz Artur, Żmudka Krzysztof. Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial).. The American journal of cardiology. 2018. DOI: 10.1016/j.amjcard.2018.02.046.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.